HLF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Herbalife Ltd (HLF) is not a strong buy for a beginner long-term investor at this time. While there are some positive technical indicators and moderate analyst support, the company's financial performance shows significant declines in net income and EPS. Additionally, there are no strong proprietary trading signals or recent congress trading data to support an immediate buy decision. The investor should consider waiting for clearer positive catalysts or improved financial performance before committing to this stock.
The technical indicators show a mixed picture. The MACD is above 0 and positively contracting, indicating potential bullish momentum. The RSI is neutral at 61.875, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock recently experienced a significant regular market price drop of -4.26%, which raises concerns about short-term sentiment.
Recent price target upgrades by Citi and Mizuho, with Citi maintaining a Buy rating and highlighting strong Q4 momentum.
The company's efforts to optimize its capital structure through an $800 million senior secured notes offering.
Significant declines in net income (-52.00% YoY) and EPS (-53.45% YoY) in the latest quarter.
Neutral trading sentiment from hedge funds and insiders, with no significant trading activity.
Regular market price drop of -4.26%, indicating weak short-term sentiment.
In Q4 2025, Herbalife reported a 6.26% YoY increase in revenue to $1.283 billion. However, net income dropped by -52.00% YoY to $85.4 million, and EPS fell by -53.45% YoY to $0.81. Gross margin slightly declined by -0.40% YoY to 77.53%.
Analysts have mixed views on Herbalife. Citi raised its price target to $21 and maintains a Buy rating, citing strong Q4 momentum. Mizuho raised its target to $15 with a Neutral rating, while BofA raised its target to $9 but maintains an Underperform rating. The overall sentiment is cautiously optimistic but not overwhelmingly positive.
